JC
Jair Chagas
I'm working on
3 months ago
A monoclonal antibody (mAb) that inhibits the proteolytic enzyme, human kallikrein 7, responsible for skin desquamation and central in the development of Atopic Dermatitis. The mAb has granted patent in the USA ( Patent No.: US 12,590,170 B2
Date: Mar. 31, 2026, Puzer et al.
I'm looking for
3 months ago
Funding and/or co-development. We are in TRL 4-5.
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.